Loading clinical trials...
Loading clinical trials...
This study aims to develop a follow-up telephone-based genetic counselling (FTGC) intervention for women with a BRCA1 or BRCA2 mutation who have received genetic counseling in the past. Typically, whe...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Women's College Hospital
Collaborators
NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more
NCT07527741 · Early-stage HER2+ Breast Cancer
NCT07558733 · HR+ HER2- Breast Cancer
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
London Regional Cancer Centre
London, Ontario
Women's College Hospital
Toronto, Ontario
Princess Margaret Hospital
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions